Asymmetry Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $10.3M | Sell |
225,032
-21,304
| -9% | -$971K | 5.45% | 8 |
|
|
2021
Q3 | $8.8M | Buy |
+246,336
| New | +$8.8M | 5.29% | 8 |
|
|
2020
Q4 | – | Sell |
-340,253
| Closed | -$7.37M | – | 36 |
|
|
2020
Q3 | $7.37M | Buy |
340,253
+134,167
| +65% | +$2.9M | 4.73% | 6 |
|
|
2020
Q2 | $4.86M | Buy |
206,086
+1,835
| +0.9% | +$43.2K | 3.72% | 10 |
|
|
2020
Q1 | $2.41M | Buy |
204,251
+119,079
| +140% | +$1.4M | 2.63% | 15 |
|
|
2019
Q4 | $904K | Buy |
+85,172
| New | +$904K | 1.62% | 29 |
|